Table 2.
Time-lagged associations of baseline MDE predicting the persistence of GAD and of baseline GAD predicting the persistence of MDE by cohort in the NCS-2 panel sample
Cohorts (Age at baseline) | ||||||||
---|---|---|---|---|---|---|---|---|
Total | 15–24 | 25–39 | 40–54 | |||||
OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | OR | (95% CI) | |
I. Baseline MDE predicting the persistence of GAD | ||||||||
MDE | 1.2 | (0.9–1.7) | 1.2 | (0.5–2.6) | 1.1 | (0.7–1.8) | 1.3 | (0.8–2.1) |
AOO of GAD | 0.9* | (0.7–1.0) | 0.9 | (0.4–1.9) | 0.8 | (0.7–1.0) | 0.8* | (0.6–1.0) |
(n)2 | (531) | (74) | (258) | (199) | ||||
II. Baseline GAD predicting the persistence of MDE | ||||||||
GAD | 1.8* | (1.4–2.4) | 2.6* | (1.4–4.6) | 1.5* | (1.1–2.2) | 1.9* | (1.3–2.7) |
AOO of MDE | 0.8* | (0.7–0.9) | 0.4* | (0.2–0.8) | 0.7* | (0.6–0.9) | 0.9 | (0.8–1.1) |
(n)2 | (1442) | (313) | (698) | (431) |
Significant at the .05 level, two-sided test
Based on a discrete-time survival model with person-year as the unit of analysis, controlling for cohort (age at interview), gender, race-ethnicity, and person-year.
Unweighted sample sizes